Kristensen Group – University of Copenhagen

Forward this page to a friend Resize Print Bookmark and Share

Department of Drug Design and Pharmacology > Research > Medicinal Chemistry Research > Chemistry and Medicinal Chemistry > Kristensen Group

Kristensen Group

Kristensen Group

Medicinal Chemistry


The design and synthesis of new

ligands is at the core of our research

Development of new PET-ligands

towards different CNS targets

Research Focus

Generally medicinal chemistry and the development of new methodology for the construction of compound classes of relevance to medicinal chemistry. Using these tools we are trying to develop new probes and tools that will help us to elucidate the underlying mechanisms responsible for the regulation of different pharmacological targets: Ion channels, enzymes and GPCR’s.

Erythrina Alkaloids
5-HT2A Agonists

Co-founder of Dep-Xplora

Dep-Xplora is a biotec company developing a novel prodrug principle to deliver NSAIDs into joints. Based on our patented technology we are currently working on bringing our lead compound into phase 1 trials.

Master projects

We offer a wide variety of different projects within the areas of organic/total synthesis, Medicinal Chemistry and Radiopharmaceuticals/PET-ligands.

Recent Masterprojects

Emil Glibstrup: Synthetic strategies towards the CD-rings of DHBE.
Morten Borch: Synthesis and Biological Evaluation of Erythrina Alkaloid Analogues.
Ida Nymann Petersen: Total Synthesis of Pyridoacridines.
Sebastian Leth-Petersen: Synthetic tools for the study of consciousness.

Please contact Jesper L. Kristensen for further information.


Please see GoogleScholar or ResearchGate for an updated list of publications.